CA
NZ
UK
AU
IND
US
SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) is trading at $8.32 pre-market June 22, up 3.35% from the June 18 close of $8.05. SELLAS is a late-stage clinical biopharmaceutical company developing novel cancer immunotherapies, with lead candidate galinpepimut-S (GPS), a peptide immunotherapy targeting the …
Definium Therapeutics, Inc. (NASDAQ: DFTX), formerly known as Mind Medicine (MindMed) Inc., is trading at $27.38 pre-market June 22, up 11.85% from the June 18 close of $24.48. Definium is a New York-based late-stage clinical biopharmaceutical company developing next-generation psychedelic-based therapeutics targeting underlying causes …
Nektar Therapeutics (NASDAQ: NKTR) is trading at $63.89 pre-market June 22, up 4.77% from the June 18 close of $60.98. Nektar is a clinical-stage biopharmaceutical company focused on immunological dysfunction in autoimmune, chronic inflammatory diseases, and oncology, with lead asset rezpegaldesleukin (REZPEG/NKTR-358), a first-in-class …
Oruka Therapeutics, Inc. (NASDAQ: ORKA) is trading at $78.45 pre-market June 22, up 8.45% from the June 18 close of $72.34. Oruka is a clinical-stage biotechnology company developing best-in-class monoclonal antibody therapeutics for chronic skin diseases including plaque psoriasis, psoriatic arthritis, and hidradenitis suppurativa, …
MoonLake Immunotherapeutics (NASDAQ: MLTX) is trading at $23.05 pre-market June 22, up 20.01% from the June 18 close of $19.21. MoonLake is a clinical-stage biopharmaceutical company developing sonelokimab, a tri-specific IL-17A and IL-17F inhibiting Nanobody for inflammatory skin and joint diseases including hidradenitis suppurativa, …
Merck & Co., Inc. (NYSE: MRK) is trading at $113.18 pre-market June 22, down 0.61% from the June 18 close of $113.87. Merck is an American multinational pharmaceutical company offering a broad portfolio spanning oncology, vaccines, infectious diseases, cardiovascular conditions, immunology, and veterinary medicine, …
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) is trading at $17.58 pre-market June 22, up 6.79% from the June 18 close of $16.46. Aurinia is a commercial-stage biopharmaceutical company developing and commercialising innovative therapies for autoimmune diseases, with flagship product LUPKYNIS (voclosporin) as the first FDA-approved …
Apogee Therapeutics, Inc. (NASDAQ: APGE) is trading at $139.34 pre-market June 22, up 54.17% from the June 18 close of $90.38. Apogee is a clinical-stage biotechnology company developing differentiated biologics for atopic dermatitis, COPD, asthma, eosinophilic esophagitis, and other inflammatory and immunology indications using …
Eli Lilly and Company (NYSE: LLY) is trading at $1,103.00 pre-market June 22, up 0.44% from the June 18 close of $1,098.57. Lilly is a leading American multinational pharmaceutical company developing innovative medicines spanning cardiometabolic health, oncology, immunology, and neuroscience, with blockbuster GLP-1 treatments …
Immunovant, Inc. (NASDAQ: IMVT) is trading at $37.89 pre-market June 22, up 7.22% from the June 18 close of $35.34. Immunovant is a clinical-stage immunology company developing innovative anti-FcRn monoclonal antibody therapies to enable normal lives for patients with autoimmune diseases, with lead candidates …
Please wait processing your request...